Methods of Reducing Tissue Taurine Levels

  • Joel E. Shaffer
  • James J. Kocsis
Part of the Monographs of the Physiological Society of Philadelphia book series (MPSP, volume 7)

Abstract

Although high levels of taurine occur in heart and other tissues of a wide variety of species (Jacobsen and Smith, 1968; Kocsis et al., 1976), the function(s) of taurine in these extrahepatic tissues is not well established. Development of methods to reduce tissue taurine levels should prove useful in determining the functional roles of tissue (intracellular) as opposed to plasma (extracellular) taurine. A basis for developing such a method is the use of structural analogues of taurine that inhibit taurine transport. Among analogues known to inhibit taurine transport in vitro are beta-alanine, the carboxylic acid analogue of taurine; γ-aminobutyric acid (GABA), the homologue of beta-alanine; and taurocyamine, the guanidino analogue of taurine (Goldman and Scriver, 1967; Gaut and Nauss, 1976; Grosso et al., 1978). Beta-alanine has been shown to greatly increase the urinary excretion of taurine in mice (Gilbert et al., 1960) and rats (Kocsis and Kostos, 1963; Shaffer and Kocsis, 1978). The hypertaurinuria induced by such taurine analogues measures their ability to mobilize tissue taurine, since taurine displayed from tissue into plasma is not reabsorbed as efficiently by the renal tubules as other amino acids (Goldman and Scriver, 1967).

Keywords

Vortex DMSO Retina Diarrhea Barium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gaut, Z. N.; and Nauss, C. B. Uptake of taurine by human blood platelets: A possible model for brain. In Taurine, Huxtable, R.; and Barbeau, A., eds. Raven Press, New York (1976), pp. 91–98.Google Scholar
  2. Gilbert, J. B.; Ku, Y.; Rogers, L. L.; and Williams, R. J. The increase in urinary taurine after intraperitoneal administration of amino acids to the mouse. J. Biol. Chem., 235, 1055–1060 (1960).PubMedGoogle Scholar
  3. Goldman, H.; and Scriver, C. R. A transport system in mammalian kidney with preference for β-amino compounds. Pediatr. Res., 1, 212–213 (1967).CrossRefGoogle Scholar
  4. Graff, J.; and Haberman, H.D. On the metabolism of β-alanine. J. Biol. Chem., 186, 369–372 (1950).PubMedGoogle Scholar
  5. Grosso, D. S.; Roeske, W. R.; and Bressler, R. Characterization of a carrier-mediated transport system for taurine in the fetal mouse heart in vitro. J. Clin. Invest., 61, 944–952 (1978).PubMedCrossRefGoogle Scholar
  6. Huxtable, R.; and Bressler, R. Taurine and isethionic acid: Distribution and interconversion in the rat. J. Nutr., 102, 805–814 (1972).PubMedGoogle Scholar
  7. Huxtable R. J.; Laird, H. E.; and Lippicott, S. Rapid depletion of tissue taurine content by guanidinoethyl sulfonate. This volume, Chap. 18.Google Scholar
  8. Iwata, H.; Yamagami, S.; Lee, E.; Matsuda, T.; and Baba, A. Increase of brain taurine contents of El mice by physiological stimulation. Japan. J. Pharmacol., 29, 503–507 (1979).CrossRefGoogle Scholar
  9. Jacobsen, J. G.; and Smith, L. H., Jr. Biochemistry and physiology of taurine and taurine derivatives. Physiol. Rev., 48, 424–511 (1968).PubMedGoogle Scholar
  10. Kocsis, J. J.; and Kostos, V. J. Taurinuria and depletion of tissue taurine stores in rats treated with beta-alanine. Pharmacologist, 5, 268 (1963).Google Scholar
  11. Kocsis, J. J.; Kostos, V. J.; and Baskin, S. I. Taurine levels in the heart tissues of various species. In Taurine, Huxtable, R.; and Barbeau, A., Raven Press, New York (1976), pp. 145–153.Google Scholar
  12. Laird, H. E.; and Huxtable, R. J. Taurine and audiogenic epilepsy. In Taurine and Neurological Disorders, Barbeau, A.; and Huxtable, R., eds. Raven Press, New York (1978), pp. 339–357.Google Scholar
  13. Marmo, E. Effects of different drugs with β-adrenolytic activity in experimental models of arrhythmias. N.S. Arch. Pharmacol., 269, 231–247 (1971).Google Scholar
  14. Minato, A.; Hirose, S.; Agiso, T.; Uda, K.; Takigawa, Y.; and Fujihira, E. Distribution of radioactivity after administration of taurine -35S in rats. Chem. Pharm. Bull., 17, 1498–1504 (1969).PubMedGoogle Scholar
  15. Morrison, J. F.; Ennor, A. H.; and Griffiths, D. E. The preparation of barium monophospho-taurocyamine. Biochem. J., 68, 447–452 (1958).PubMedGoogle Scholar
  16. Nara, Y.; Yamori, Y.; and Lovenberg, W. Effect of dietary taurine on blood pressure in spontaneously hypertensive rats. Biochem. Pharmacol, 27, 2689–2692 (1978).PubMedCrossRefGoogle Scholar
  17. Nutzenadel, W.; and Scriver, C. R. Uptake and metabolism of β-alanine and L-carnosine by rat tissues in vitro: Role in nutrition. Am. J. Physiol., 230, 643–651 (1976).PubMedGoogle Scholar
  18. Pihl, A.; and Fritzson, P. The catabolism of C14-labeled β-alanine in the intact rat. J. Biol Chem., 215, 345–351 (1955).PubMedGoogle Scholar
  19. Schaffer, S. W.; Chovan, J.; Kramer, J.; and Kulakowski, E. The role of taurine receptors in the heart. This volume, Chap. 20.Google Scholar
  20. Schmidt, S. Y.; Berson, E. L.; and Hayes, K. C. Retinal degeneration in cats fed casein: I. Taurine deficiency. J. Invest. Ophthalmol., 15, 47–52 (1976).Google Scholar
  21. Scriver, C. R.; Pueschel, S.; and Davies, E. Hyper β-alaninemia associated with β-aminoaciduria and α-aminobutyricaciduria, somnolence and seizures. N. Engl. J. Med., 274, 635–643 (1966).PubMedCrossRefGoogle Scholar
  22. Shaffer, J. E.; and Kocsis, J. J. Taurine mobilizing effects of beta alanine in rats. Fed. Proc, 37 (3), 2963 (1978).Google Scholar
  23. Shaffer, J. E.; Kramer, J.; Schaffer, S. W.; and Kocsis, J. J. Intracellular or extracellular effects of taurine? Fed. Proc., 38, 695 (1979).Google Scholar
  24. Spaeth, D. G.; and Schneider, D. L. Turnover of taurine in rat tissues. J. Nutr., 104, 179–186 (1974).PubMedGoogle Scholar
  25. Sturman, J. A. Taurine pool sizes in the rat: Effects of vitamin B-6 deficiency and high taurine diet. J. Nutr., 103, 1566–1580 (1973).PubMedGoogle Scholar
  26. Sturman, J. A.; Rassin, D. K.; Hayes, K. C; and Gaull, G. E. Taurine deficiency in the kitten: Exchange and turnover of 35S-taurine in brain, retina and other tissues. J. Nutr., 108, 1462–1476 (1978).PubMedGoogle Scholar
  27. Tokunaga, H.; Yoneda, Y.; and Kuriyama, K. Protective actions of taurine against streptozo-tocin-induced hyperglycemia. Biochem. Pharmacol., 28, 2807–2811 (1979).PubMedCrossRefGoogle Scholar
  28. Vessey, D. A. The biochemical basis for the conjugation of bile acids with either glycine or taurine. Biochem. J., 174, 621–626 (1978).PubMedGoogle Scholar

Copyright information

© Spectrum Publications, Inc. 1981

Authors and Affiliations

  • Joel E. Shaffer
  • James J. Kocsis

There are no affiliations available

Personalised recommendations